Edwards Lifesciences
North America, California, United States, Irvine
Description
Edwards Lifesciences is a provider of science of heart valves and hemodynamic monitoring.
Investor Profile
Edwards Lifesciences has backed more than 12 startups, with 1 new investments in the last 12 months alone. The firm has led 3 rounds, about 25% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Series D rounds (top funding stages).
- Majority of deals are located in United States, Israel, France.
- Strong thematic focus on Health Care, Medical Device, Biotechnology.
- Led 1 rounds in the past year.
Stage Focus
- Series C (25%)
- Series B (25%)
- Series D (8%)
- Series E (8%)
- Post Ipo Equity (8%)
- Series A (8%)
- Series F (8%)
- Corporate Round (8%)
Country Focus
- United States (67%)
- Israel (17%)
- France (8%)
- Singapore (8%)
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
Industry Focus
- Health Care
- Medical Device
- Biotechnology
- Medical
- Architecture
- Manufacturing
- Health Diagnostics
- Pharmaceutical
- Software
- Wireless
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Edwards Lifesciences frequently co-invest with?
Which angels does Edwards Lifesciences often collaborate with?
What are some of recent deals done by Edwards Lifesciences?
Find More Investors Like Edwards Lifesciences
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
